Page 2 - Medical Research

Ethnic diversity helps identify more diabetes-related genomic regions

By including multi-ethnic participants, a large-scale genetic study by the University of Exeter has identified more regions of the genome linked to type-2 diabetes-related traits

Why can't models get Covid-19 predictions right? Should we rely on them?

The models did work to a certain extent. The purpose of the models was not to do long-term forecasting but to inform public opinion and guide policy decisions

Cadila Healthcare testing two-shot regimen for ZyCoV-D, data likely by May

The company is conducting phase 3 efficacy trials on a three-dose regimen of its DNA plasmid technology-based Covid-19 vaccine, which is in its last leg

IT veteran Ashok Soota sets up non-profit entity for medical research

IT veteran Ashok Soota has set up SKAN, a not-for-profit entity that will conduct medical research, and has committed Rs 200 crore towards the effort. The research for the projects will be done through reputed partners, a statement said on Sunday. The strategic partner for neurological research is the Centre for Brain Research (CBR) at Indian Institute Science-Bangalore (IISc), it added. CBR is putting together a consortium to handle the first project on Parkinson's disease. The strategic partner for ageing is the upcoming St. John's Geriatric Centre (SJGC), to be located on the St John's Hospital campus. "Soota has agreed to fund the setting up of the Centre for Research in Ageing and Geriatrics (CRAG) at the SJGC and to support joint projects," according to the statement. Of this, Rs 100 crore is earmarked for partners such as St John's, Centre for Brain Research (CBR), IIT-Roorkee, NIMHANS and any new partners which may be added. The remaining amount is earmarked for investmen

Triumph for science

The speed record of Covid-19 vaccine launches is extraordinary

Cost control steps, operational efficiency drive Sygene's Q3 net up by 11%

Consolidated revenue rises by 11.59 per cent to Rs 601.6 crore

Covid-19 vaccine: I am not worried about the efficacy, says Jacob John

I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment, the former head of Centre for Advanced Research in Virology at ICMR says

Study shows new research that may explain severe virus attacks on lungs

How different kinds of immune cells develop in the lungs and which of them may be behind severe lung diseases, has been described in a new study by researchers at Karolinska Institutet in Sweden

Will explore more investments if incentivised by the govt: Medtronic

Atmanirbharta can be achieved when design and development in India are part of the plan, said the company

Children, adults produce different antibodies against Covid-19: Study

Children and adults produce different types of antibodies in response to the novel coronavirus, according to a study which suggests the course of infection and immune response is distinct in kids

Treating Covid may lead to increased antibiotic resistance, UK study finds

The use of antibiotics in people with Covid-19 could lead to raised levels of the drugs within rivers which may in turn result in an increase in antimicrobial resistance, according to a UK study

UK, India to collaborate in 8 mn pounds-anti-microbial resistance research

UK and India are deepening scientific research collaboration with five new projects to tackle AMR that could lead to advances in the global fight against antibiotic-resistant bacteria and genes

GSK buys 10% stake of German biotech firm CureVac in $164-million deal

GSK and CureVac, backed by Bill Gates, will work on developing up to five so-called mRNA-based vaccines and monoclonal antibodies (mAbs) for infectious diseases, they said.

Why vaccines can't be launched overnight

Under normal circumstances, the development of new vaccines and treatments could take 10-20 years

Lakshmi Mittal gifts GBP 3.5 mn to Oxford for developing Covid-19 vaccine

Lakshmi Mittal said, "This year has been a wake-up call to the world to be better prepared for pandemics, which, as we have all experienced, can cause massive social and economic disruption."

IIT Kanpur partners with Bharat Dynamics for manufacturing ventilators

The indigenous ventilator has been developed by IIT Kanpur's incubated startup

Scientists question validity of major hydroxychloroquine study

A spokeswoman for Mandeep R Mehra, the Harvard professor who was the paper's lead author, said on Friday that the study's authors had asked for an independent academic review and audit of their work.

Oxford University's Covid-19 vaccine moves to next stage of human trials

The first phase of the trial began last month with 1,000 healthy adults aged 55 and under as volunteers.

June Almeida, scientist who identified the first coronavirus

In 1966, she used a powerful electron microscope to capture an image of a mysterious pathogen - the first coronavirus known to cause human disease.

Can Ganga water treat Covid-19? ICMR says no to study, need more data

Evidence and data available at the moment is not strong enough to start the clinical studies, said Dr Y K Gupta